COVID-19: Biggest AstraZeneca jab maker unlikely to resume major exports 'for at least three months' as it keeps doses for India surge

The world's biggest maker of the AstraZeneca vaccine is unlikely to resume major exports until at least October as it prioritises doses for India's coronavirus crisis.